Lexapro, Celexa and depression
Last week’s FDA approval of Lexapro to treat depression in adolescents 12-17 years old got me to thinking both about bureaucratic nonsense and corporate shenanigans. That’s because, in a classic case of bureaucratitis, the FDA approval came just weeks after Justice Department prosecutors, following a 5-year investigation, accused Forest Laboratories of illegally marketing Lexapro for use in these very same children. Of course, such actions are not mutually exclusive because, in fact, it would have been illegal for Forest to promote the use of Lexapro in kids prior to such an FDA approval, but, really, when one arm of the government says it’s now fully convinced of Lexapro’s efficacy in children doesn’t it seem a bit odd that another arm would be spending so much time and effort prosecuting the company for promoting such use? Shouldn’t they be going after companies promoting things that don’t actually work? Maybe yes, maybe […]
Original post by admin and weightlossopinions.com
